Good luck to the people who were kept on. All of Amgen will be watching the rare disease BU and the layoffs targeted the people who kept things running in the background. Do you think Amgen is going to step in and provide that internal support? They don't even know how we get stuff done around here.
Not to mention the compensation cuts.. that email with the fancy formula on calculating 2024 LTI targets? A lot of words to say "we're screwing you".